• FOLLOW US
Video Player
  • Email
  • share

J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials By May

Johnson & Johnson plans to roll out an Ebola vaccine it is working on developing for clinical trials by May. The vaccine combines a shot from its Janssen unit in the Netherlands with one developed by Danish biotechnology company Bavarian Nordic. J&J

http://www.wgrz.com/video/3852910546001/1/JJ-Sees-250000-Ebola-Vaccine-Doses-Ready-for-Trials-By-May http://cdn.newslook.com/3c/3ccf788691518b4c7772e35f0c992a59/images/frame_ext.jpg J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials By May Johnson & Johnson plans to roll out an Ebola vaccine it is working on developing for clinical trials by May. The vaccine combines a shot from its Janssen unit in the Netherlands with one developed by Danish biotechnology company Bavarian Nordic. J&J J&JyoutubenewslookUnited States of AmericaAfricaEuropenetherlands 01:01

Next Up

    

More Videos